alvocidib
Showing 26 - 50 of 52
Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia Trial in
Completed
- Recurrent Adult Acute Lymphoblastic Leukemia
- +4 more
- cytarabine
- +4 more
-
Baltimore, MarylandJohns Hopkins University
Oct 7, 2013
B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +9 more
- alvocidib
- +2 more
-
Columbus, OhioOhio State University Medical Center
Jul 1, 2013
Solid Tumor Trial in New York (alvocidib, irinotecan HCl, fluorouracil)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 3, 2013
Liver Cancer Trial in New York (alvocidib, irinotecan HCl)
Completed
- Liver Cancer
- alvocidib
- irinotecan hydrochloride
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 21, 2013
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer Trial in New York (drug, radiation,
Completed
- Adenocarcinoma of the Pancreas
- +4 more
- alvocidib
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 3, 2013
Esophageal Cancer Trial in New York (alvocidib, paclitaxel)
Completed
- Esophageal Cancer
- alvocidib
- paclitaxel
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 20, 2013
Solid Tumor Trial in New York (alvocidib, cisplatin, paclitaxel)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 20, 2013
Breast Cancer Trial run by the NCI (alvocidib, docetaxel)
Completed
- Breast Cancer
- alvocidib
- docetaxel
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 14, 2013
Gastrointestinal Stromal Tumor, Recurrent Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in New York
Completed
- Gastrointestinal Stromal Tumor
- +2 more
- alvocidib
- doxorubicin hydrochloride
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 18, 2013
Head Neck Cancer, Thromboembolism Trial run by the NCI (acetylsalicylic acid, alvocidib, clopidogrel bisulfate)
Completed
- Head and Neck Cancer
- Thromboembolism
- acetylsalicylic acid
- +2 more
-
Bethesda, Maryland
- +1 more
Jun 17, 2013
Solid Tumor Trial in New York (alvocidib, docetaxel)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- docetaxel
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
May 29, 2013
B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular
Completed
- B-cell Chronic Lymphocytic Leukemia
- +42 more
- alvocidib
- +3 more
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
Solid Tumor Trial in Detroit (alvocidib, docetaxel)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- docetaxel
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 3, 2013
Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma
Completed
- Recurrent Childhood Brain Stem Glioma
- +21 more
- alvocidib
- pharmacological study
-
Arcadia, CaliforniaCOG Phase I Consortium
Jul 1, 2013
Solid Tumor Trial in Boston (alvocidib, gemcitabine HCl)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- gemcitabine hydrochloride
-
Boston, Massachusetts
- +1 more
Feb 27, 2013
Leukemia, Lymphocytic, Chronic Trial in Worldwide (alvocidib)
Completed
- Leukemia, Lymphocytic, Chronic
- alvocidib
-
San Diego, California
- +33 more
Feb 8, 2013
Prostate Cancer Trial in United States (alvocidib)
Completed
- Prostate Cancer
- alvocidib
-
Duarte, California
- +3 more
Feb 8, 2013
HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Boston (biological, drug, other)
Terminated
- HER2-positive Breast Cancer
- +3 more
- trastuzumab
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 31, 2013
Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (alvocidib)
Completed
- Refractory Multiple Myeloma
- +3 more
- alvocidib
-
Rochester, MinnesotaMayo Clinic
Jan 15, 2013
Solid Tumor Trial in Albuquerque (alvocidib, gemcitabine HCl, irinotecan HCl)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- alvocidib
- +2 more
-
Albuquerque, New MexicoUniversity of New Mexico
Jan 24, 2013
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +5 more
- alvocidib
- laboratory biomarker analysis
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 16, 2013
Lymphoma Trial in United States (alvocidib)
Completed
- Lymphoma
- alvocidib
-
Chicago, Illinois
- +9 more
Feb 4, 2013
Endometrial Cancer Trial in Worldwide (alvocidib)
Completed
- Endometrial Cancer
- alvocidib
-
Birmingham, Alabama
- +53 more
Jun 20, 2013
Kidney Cancer Trial in United States (alvocidib)
Completed
- Kidney Cancer
- alvocidib
-
Birmingham, Alabama
- +100 more
Jun 20, 2013
Breast Cancer, Melanoma (Skin), Prostate Cancer Trial in Rochester (alvocidib, carboplatin, cisplatin)
Completed
- Breast Cancer
- +3 more
- alvocidib
- +2 more
-
Rochester, MinnesotaMayo Clinic
Aug 2, 2011